EP3134505A1 - Procédé et dispositif de purification de molécules biologiques - Google Patents

Procédé et dispositif de purification de molécules biologiques

Info

Publication number
EP3134505A1
EP3134505A1 EP15717482.2A EP15717482A EP3134505A1 EP 3134505 A1 EP3134505 A1 EP 3134505A1 EP 15717482 A EP15717482 A EP 15717482A EP 3134505 A1 EP3134505 A1 EP 3134505A1
Authority
EP
European Patent Office
Prior art keywords
filter
cells
pumped
vessel
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15717482.2A
Other languages
German (de)
English (en)
Inventor
Bernd Faltin
Christian Dorrer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robert Bosch GmbH
Original Assignee
Robert Bosch GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Bosch GmbH filed Critical Robert Bosch GmbH
Publication of EP3134505A1 publication Critical patent/EP3134505A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/16—Microfluidic devices; Capillary tubes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/02—Separating microorganisms from the culture medium; Concentration of biomass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/06—Hydrolysis; Cell lysis; Extraction of intracellular or cell wall material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/10—Separation or concentration of fermentation products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12—Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes

Definitions

  • the present invention relates to a method and an apparatus for the purification of biological molecules, in particular of nucleic acids or proteins, wherein at least one filter is used in the method.
  • Nucleic acids or proteins exist in many different ways.
  • the biological molecules are obtained from cell material, ie from prokaryotic or eukaryotic cells. Before intracellular material can be further processed, it is usually necessary to open the cells themselves. This cell disruption is commonly referred to as cell lysis. After separation of cell debris, for example
  • Nucleic acids, proteins or peptides are further purified, processed and analyzed. When referring to proteins in the following, they also mean peptides.
  • the purified nucleic acids can be amplified selectively by PCR (Polymerase Chain Reaction) so that the particular nucleic acid sequence is made detectable.
  • the digestion of the cells can take place in different ways.
  • An enzymatic digestion of the cells is widespread, for example, a treatment with the enzyme proteinase K or lysozyme is performed.
  • a thermal cell disruption by heating and / or freezing the sample or a cell disruption with chemical reagents is also possible.
  • the Cell disruption done mechanically, for example by a
  • a common method for further purification of, for example, nucleic acids provides that the so-called lysate resulting from cell disruption is mixed with a binding buffer and brought into contact with a solid matrix, for example a silica filter or a silica membrane.
  • a solid matrix for example a silica filter or a silica membrane.
  • the nucleic acids adsorb to the filter and can then be washed with a washing buffer and then eluted from the solid matrix and used further.
  • Various commercially available kits and laboratory equipment work according to this principle.
  • German laid-open specification DE 10 2005 009 479 A1 describes a method in which the cells are accumulated by means of filtration.
  • German Offenlegungsschrift DE 10 2010 030 962 A1 describes a method for the hybridization of nucleic acids in a microarray, in which the sample is first pumped through a denaturation unit and then through a separate reaction area with the microarray with the immobilized probes.
  • the pumping section can be configured as a circuit.
  • German patent application DE 10 2010 043 015 AI discloses a
  • Nucleic acid containing cells take place on the filter.
  • biological molecules in particular nucleic acids or proteins or other biological molecules
  • the purification is carried out in principle by a non-specific adsorption of the biological molecules to a matrix, in particular to a membrane.
  • a filter which hereby means the matrix, in particular in the form of a membrane or, for example, in the form of a bed.
  • the core of the invention is that at least some of the required for the process management
  • the steps of the method according to the invention initially comprise pumping a liquid with biological cells, that is to say a sample liquid, via the filter.
  • biological cells is generally understood to mean cells from which biological molecules, such as, for example, nucleic acids or proteins, are to be treated or purified, for example pathogenic microorganisms such as bacteria or fungi is also suitable for human cells or other cells and can be used in general for the purification of proteins or nucleic acids from prokaryotic or eukaryotic cells
  • sample liquid is generally understood to mean the liquid containing the corresponding cells, for example one
  • Cell suspension or a patient sample for example, blood, lavage, urine, cerebrospinal fluid, sputum or a flushed Swab or smear.
  • the volume of the sample may be different, for example, between a few ⁇ to 10 ml.
  • the cells retained on the filter are digested, whereby in principle different methods can be used for cell disruption.
  • the biological molecules contained in the cell lysate are bound to the filter by means of a binding buffer, whereby the binding buffer is pumped in circulation via the filter.
  • the biological molecules bound to the filter are cleaned in the subsequent step with wash buffer, which is pumped over the filter.
  • wash buffer which is pumped over the filter.
  • the bound biological molecules may be eluted from the filter in a conventional manner, or the filter having the reversibly immobilized biological molecules may be used directly as such.
  • the particular effectiveness of the purification process according to the invention is achieved in that the substances are rinsed several times through the filter by the circulation of the liquids, in particular during the binding process of the biological molecules to the filter.
  • the filter material is repeatedly contacted with the fluids. It turns
  • the circular fluid guide provided according to the invention achieves thorough mixing of the various reagents and buffers, which makes the method of the invention particularly suitable for implementation within a microfluidic system. Irrespective of this, the mixing efficiency, in particular in a microfluidic system, can also be increased by further measures, in particular by means of mixer structures or mixing chambers known per se, in a microfluidic system.
  • an accumulation of the biological cells takes place, wherein the cells are retained on the filter according to the size exclusion method and / or by electrostatic interactions when the sample liquid is pumped over the filter.
  • the more sample liquid is pumped through the filter the higher the number of accumulated cells.
  • the diameter of such a known filter may be different, for example between 1 and 25 mm.
  • Suitable filters are, for example, fiber filters, fabric filters and / or membrane filters, in particular of silica.
  • particle beds are also suitable.
  • Microparticle beds e.g. from silica particles.
  • the pore diameter of the materials is preferably below 100 ⁇ m.
  • the digestion of the cells can take place in various ways, for example mechanically or by heat.
  • an ultrasonic treatment which can be carried out with relatively little expenditure on equipment. In this case, no additional reagents for lysis or cell disruption are required.
  • the ultrasound can be entered directly into the filter.
  • the wall of a corresponding filter chamber be designed as a membrane into which the
  • Ultrasound is coupled by means of a horn. During the
  • the filter chamber should be filled with liquid or with a buffer or water.
  • the ultrasonic treatment may cause the filter material to be partially disassembled.
  • the cells accumulated in the filter are at least partially released and made accessible to the lysis effect by the ultrasound.
  • the resulting particles can produce an additional grinding effect and thereby further support cell disruption, with the particles being caught again by the intact areas of the filter in the further course of the processing.
  • cell disruption using enzymes or other lysing reagents for example chemical reagents.
  • lysing reagents can be provided with particular advantage also a circulation of the fluids.
  • a suitable lysis buffer is fed into the circular fluidic path and pumped in a circle over the filter. It is pumped in particular in the direction in which the sample was pumped through the filter. This avoids the loss of cells or already released nucleic acids when the lysis buffer is initially placed on the filter. Furthermore, air bubbles, which possibly reach the filter, in the course again removed from this. In the previously known methods, such air bubbles remain on the filter and locally prevent lysis. Furthermore, the leaching of the lysis reagents on the filter is thereby avoided by the continuous introduction of lysis buffer on the cells, thus achieving a particularly effective and complete lysis of the cells on the filter.
  • a lysis buffer is to be understood as meaning a buffer which is suitable for cell disruption or lysis of the target cells.
  • the buffer may contain, for example, lysis enzymes known per se, such as, for example, lysozyme and / or
  • Proteinases Alternatively or additionally, chaotropic salts, detergents and / or basic ingredients such as e.g. NaOH be included. Further, buffering agents (e.g., Tris-HCl), nuclease inhibitors (e.g., EDTA or EGTA) and / or reducing agents (e.g., ⁇ -mercaptoethanol) may be included.
  • buffering agents e.g., Tris-HCl
  • nuclease inhibitors e.g., EDTA or EGTA
  • reducing agents e.g., ⁇ -mercaptoethanol
  • the binding buffer is fed into the circular fluidic path and pumped in a circle.
  • the binding buffer mixes with the lysate and, for example, the nucleic acids bind to the filter under the conditions set in the process.
  • a buffer suitable for this purpose may in particular contain chaotropic reagents, for example GIT
  • the denaturation buffer is also preferably pumped in the circulation to further increase the effectiveness of the denaturation step.
  • an additional digestion step can be carried out, especially in the purification of nucleic acids.
  • Verdaupuffer can, for example, various enzymes, in particular
  • Proteinases that contain a digestion of the liberated in the lysis step Proteinases that contain a digestion of the liberated in the lysis step
  • the appropriate digestion buffer is fed into the path and advantageously also pumped in a circle.
  • wash buffer passed over the filter.
  • suitable wash buffers is chosen such that in this step, for example, the nucleic acids remain bound to the filter while other molecules, especially proteins, are not adsorbed and removed.
  • an alcohol-containing washing buffer e.g. 70% EtOH, are used.
  • the filter is dried after treatment with washing buffer. This can be done, for example, by passing air or nitrogen through the filter. Subsequently, elution of the adsorbed target molecules from the filter can be carried out using water or a suitable elution buffer for this purpose. It can also be provided that the filter with the target molecules adsorbed on it is used as such. For example, a PCR can be carried out with the reversibly immobilized on the filter nucleic acids, as is known per se from the prior art.
  • the filter When using certain samples, it may be advantageous to pre-treat the sample before applying it to the filter. For example, in the filtration of blood there may be a problem that the filter becomes clogged with blood cells and thus clogged, making further filtration impossible. For this purpose, it has proven to be advantageous to first lyse the blood cells selectively.
  • selectively lyse it is meant that the blood cells, also called human cells, are disrupted while other cells contained in the sample, especially pathogens, remain intact, for example, by treating the sample with chaotropic reagents or
  • a digestion can be incorporated into the method of the invention and have the advantage that the filterability of the sample is further improved and a human nucleic acid background is partially removed from the sample.
  • the sample is first mixed with a chaotropic buffer and then incubated with a DNase, e.g. for a period of 10 minutes before the sample is applied to the filter.
  • one or more of the method steps may be at least partially under
  • Heat supply done In particular for the cell disruption and / or the additional digestion step and / or for the drying of the filter, it may be advantageous to increase the temperature.
  • the enzymes used for enzymatic cell disruption may be elevated
  • the lysis of the cells can run faster and more effective.
  • the drying of the filter can be accelerated by increasing the temperature, for example by increasing the temperature to a temperature between 40 and 60 °.
  • the filter can be heated directly, for example via a per se known Peltier element or a film heater, which is brought into contact with the device containing the filter.
  • tempered liquids for example it can be provided, a Poperungsgefäß for the liquids used and / or the At least partially to heat the pipeline system.
  • a cooling or generally a temperature control may be advantageous.
  • Procedural steps are reversed once or several times. In this way, in particular clogging of the filter or clogging of the filter can be avoided or optionally reversed. Furthermore, the mixing of liquids in circulation can be improved and optionally precipitated solids can be brought back into solution.
  • a reversal of the pumping direction is particularly advantageous during the binding step and / or during the washing step and / or during the elution step.
  • microfluidic devices have the advantage that they are particularly suitable for automated processes. Automation reduces the time and cost of analysis and reduces the risk of contamination. Furthermore, an automated system does not necessarily have to be operated by qualified personnel, since the operation is generally easy to learn.
  • inventive method in conjunction with a microfluidic device has the particular advantage that a particularly good mixing of the liquids is achieved by the circulation of the fluids. Often, therefore, can be dispensed with further structures and active components such as stirrers for mixing. Nevertheless, however, additional mixer structures or mixing chambers known per se can also be used be provided in a corresponding device in order to further increase the mixing efficiency.
  • the invention further comprises an apparatus for carrying out a purification of biological molecules, in particular of nucleic acids or
  • the device has at least one pump for pumping liquids.
  • the device comprises at least one device for fixing at least one filter.
  • the purification protocols that can be carried out here are based on the fact that the biological molecules to be purified can adsorb to the filter. According to the invention, the
  • Device a conduit system for the circular pumping of liquids through the filter.
  • the described method according to the invention can advantageously be carried out with this device.
  • An essential aspect of the invention is that by the circular pumping of liquids through the filter, the efficiency of the cleaning process can be significantly improved.
  • the device for fixing the filter is in particular a filter chamber for receiving the filter material.
  • filter chamber is to be understood in particular as meaning a fluidic cavity with a filter, for example, the filter chamber may be designed as a tube or, in a particularly preferred manner, as a microfluidic element
  • Filter chamber preferably has a multilayer structure.
  • two or more structured plates in particular polymer plates, can be provided.
  • one of the plates can be a flat
  • Recess may be provided in which the filter, e.g. a membrane, or other filter material, e.g. a microparticle bed, can be inserted. It has proven to be advantageous, in particular with relatively large filter diameters (> 3 mm), to pass the filter through a support structure, e.g. a porous polymer carrier (frit), to aid in sagging or
  • one or more inlet and outlet channels are provided for the passage of liquids.
  • an additional membrane is inserted between the two plates, realized by the additional functionalities of the filter chamber can be, for example, a pneumatic actuation of
  • Diaphragm valves and / or a diaphragm pump Preferably cover films or cover membranes or other polymer layers are provided as lateral outer terminations of the system.
  • a cover film can also be used for coupling ultrasound.
  • the filter chamber has an extension for introducing the ultrasound.
  • This extension of the filter chamber can also take over the function of ventilation for the system, wherein
  • Ventilation channels may be provided, which lead to the extension.
  • the device according to the invention has at least one ventilated vessel, with which liquids can be introduced into the system.
  • an upwardly vented vessel may be incorporated into the fluidic path or conduit system for circular pumping of liquids across the filter.
  • the liquids may e.g. be introduced by hand, in particular by pipette, or by pumping with a second pump integrated in the system into the vessel.
  • a ventilated vessel also has the advantage that air bubbles which have entered the fluidic path can rise in the vessel and thus leave the system. This will avoid that
  • Such a vessel may for example be designed as a tube, chamber or other fluidic element having a volume, for example, between 100 ⁇ and 10 ml.
  • a plurality of ventilated vessels can be provided in the system, which can serve primarily as displacement chambers for reagents.
  • the pump may be, for example, a peristaltic pump or a micromembrane pump.
  • the pump is more or less directly upstream or downstream of the filter, so that the liquids can be pumped with very high positive or negative pressure through the filter.
  • the channel piece between the pump and the filter is relatively short.
  • an inlet channel for the sample liquids opens more or less directly in front of the pump or the filter. This has the advantage that other displacement vessels for buffer solutions are not contaminated by the sample liquid. It can also be provided that several
  • Inlet channels are provided for different liquids.
  • one or more elements of the device can be heated.
  • the pump and / or the line system or parts thereof and / or the filter and / or optionally a vessel which is provided for the pre-storage or for the introduction of liquids be heated.
  • individual process steps can be tempered
  • the lysis step may be performed at an elevated temperature by preheating the lysis buffer and / or heating the filter itself.
  • the device according to the invention is designed as a microfluidic system.
  • the advantages of the device according to the invention in microfluidic design reference is made to the advantages already mentioned above.
  • the method according to the invention and the device according to the invention can be implemented, for example, with particular advantage in molecular diagnostics and / or, for example, in a lab-on-a-chip system.
  • Fig. 1 is a schematic representation of the principle of the circular
  • Fig. 2 is a schematic representation of the components of an exemplary
  • Fig. 3 is a schematic representation of another exemplary embodiment
  • Fig. 4 is a schematic representation of another exemplary embodiment
  • Fig. 5 is a schematic representation of another exemplary embodiment
  • Fig. 6 is a schematic representation of a multilayer filter chamber as
  • Fig. 7 microfluidic device according to the invention in a plan view;
  • Fig. 8 side view of the multilayer structure of the microfluidic
  • FIG. 9 is an oblique view of the microfluidic device of FIG. 7; FIG.
  • microfluidic device in side view (Fig. 10) and in plan view (Fig. 11) and
  • FIG. 12 in plan view (FIG. 13).
  • FIG. 1 illustrates the principle of a circular fluidic path 11, which extends over a filter 10.
  • the fluid in the fluidic connections 11 is driven by a pump 12.
  • the fluidic connections 11 can be formed, for example, by hoses or channels.
  • the pump 12 is a
  • Liquid pump such as a peristaltic pump or a
  • Diaphragm pump Conventional integrable microfluidic pumps can be used for a microfluidic configuration of the device.
  • the filter 10 shown here is realized in the form of a filter chamber. The following description of a filter is to be understood in many cases as a synonym for a filter chamber.
  • the filter chamber can be called microfluidic
  • the type of inflow and outflow on the filter 10 can optionally be set exactly.
  • the filter chamber itself can be realized, for example, in a multilayer structure of a plurality of structured polymer layers. By this construction, a particularly cost-effective production is possible.
  • the pump 12 is connected via hoses to the inlet and outlet of the filter chamber 10, the feeding into the fluidic path can be done, for example, by opening the hose connection and pipetting.
  • Fig. 2 shows a preferred variant for the schematic structure of an apparatus for carrying out the method.
  • an upwardly ventilated vessel 24 is integrated into the fluidic path. Via this vessel 24 liquids can be introduced into the circular fluidic path. The required solutions or buffers can be pipetted into the vessel 24, for example. In this way, it is advantageously possible to feed buffer or other solutions into the fluidic path during the process.
  • this embodiment has the advantage that air bubbles that have entered the fluidic path, rise in the vessel 24 up and so can leave the system.
  • the volume of the vessel 24 can be selected accordingly, for example between 100 .mu.l and 10 ml.
  • the vessel 24 can be designed, for example, as a tube or as a microfluidic element.
  • the bottom of the vessel is the outlet channel of the system. By “bottom” is meant the part of the vessel that is at the lowest point in gravity
  • Liquids can be completely removed from the vessel.
  • the vessel 24 is designed so that it tapers downwards.
  • Fig. 3 shows a further variant of the device for carrying out the
  • This embodiment is particularly suitable as a microfluidic system.
  • a microfluidic system has the advantage that the dead volume of the structure can be kept very low and the risk of foaming is low.
  • the circular fluid guide in the fluidic connections 31 is driven by the pump 32. Upstream of the pump is the filter chamber 30. Further, a vessel 34th
  • the opening or the venting channel 35 is advantageously at the respect of the gravitation upper end of the vessel. As a result, inadvertent leakage of reagents can be avoided.
  • an inlet channel 36 is provided, wherein the inlet channel 36 can also open directly into the vessel 34. Furthermore, a plurality of inlet channels 36 may be present. Downstream of the pump is an outlet channel 37.
  • the flow of liquids is controlled by integrated valves 38 located at various locations in the system. This can be, for example, rotary or
  • the method according to the invention can be carried out as follows:
  • the sample ie the liquid with the biological cells, is introduced through the opening 35 into the vessel 34 via the inlet channel 36 or by introduction (eg pipetting).
  • the vessel 34 may be designed, for example, as a microfluidic cavity.
  • the air contained in the vessel 34 is released through the opening or the venting channel 35, so that the vessel 34 is vented.
  • the pump 32 then pumps the sample via the filter 30 in the direction of the outlet channel 37. Es it can be provided that the venting channel 35 is closed, so that the pump 32 can suck in the sample directly via the inlet channel 36.
  • the cells contained in the sample accumulate on the filter 30.
  • the cells are then disrupted by, for example, treating them with a suitable lysis buffer.
  • the lysis buffer is first introduced into the vessel 34, for example via the inlet channel 36.
  • the lysis buffer is pumped by the pump 32 via the circular fluidic path 31 in the circuit via the filter 30.
  • the cell disruption can also be done in other ways, for example with ultrasound.
  • the filter 30 is sonicated accordingly.
  • suitable binding buffer is introduced into the vessel 34 and pumped in the circuit 31.
  • the washing buffer is first introduced into the vessel 34 and pumped by the pump 32 via the filter 30 in the direction of the outlet channel 37.
  • drying of the filter 30 is provided, for example, air or nitrogen is pumped from the inlet channel 36 via the filter 30 in the direction of the outlet channel 37. It is also possible to use the pump 32 for drying.
  • an elution step can be carried out, wherein suitable elution buffer is introduced into the vessel 34 and pumped by the pump 32 via the filter 30 in the direction of the outlet channel.
  • the introduction of the sample and the buffer into the vessel 34 can take place, for example, by means of a further pump or manually by pipetting or the like.
  • a resealable opening in the vessel 34 may be provided.
  • FIG. 4 shows a further variant of the system, wherein in addition to the vessel 34 one or more further vessels 44, for example storage vessels, are provided. These vessels 44 are equipped with an opening or a vent channel 45. The contents of the vessel 44 can be introduced via a further valve 48 in the rest of the pipe system.
  • the system substantially corresponds to the device shown in FIG. 3. The corresponding elements are therefore provided with the same reference numerals.
  • another valve 49 is provided between the vessel 34 and the supply line from the other vessel 44.
  • Various buffers for example the lysis, digestion, denaturing, binding, washing or elution buffers, can be stored upstream in the vessel or vessels 44.
  • This variant has the advantage that an automatic implementation is simplified because the buffers no longer have to be individually introduced into the vessel 34.
  • the method can be carried out in such a way that, in particular, the sample is manually introduced into the vessel 34 before the filter 30 is subjected to it.
  • the various required buffers in the subsequent process steps can be automatically introduced from the vessel or vessels 44
  • FIG. 5 illustrates a further preferred example of a device for carrying out the method according to the invention, which can be realized, for example, in a microfluidic system.
  • the pump 52 is located upstream of the filter chamber 50. This has the advantage that liquids can be pumped through the filter 50 at very high pressure. For this purpose, it is particularly advantageous if the channel piece or piece of tubing between the pump 52 and the filter 50 is relatively short.
  • the inlet channel 56 opens directly in front of the pump 52. This has the advantage that the pumped from the inlet channel 56 via the filter 50
  • Liquids especially the sample with the cell material, not the
  • Pre-storage vessel 54 pass, so that contamination can be avoided.
  • the system can be heated partially or in sections, for example, the filter 50 and / or the pump 52 and / or the vessel 54 can be heated.
  • a heating may conveniently take place during the lysis step, so that the cell digestion can proceed even more efficiently.
  • an optimum temperature for the lysis enzymes used can be set, which may for example be in a temperature range between 35 and 55 ° Celsius, for example at 45 ° Celsius.
  • the process control in the Lyse intimid preferably takes place in a circular shape over the circular fluidic path 51, comparable to the other described embodiments.
  • further inlet channels may be present, via which the required reagents can be pumped into the system.
  • the vessel or vessels 54 have a volume of 2 ml and the filter has a diameter of between 2 and 10 mm, for example.
  • the fluid flow is controlled via the valves 58.
  • the fluids can leave the system via the outlet channel 57.
  • An experimental procedure for the accumulation and lysis of cells and a DNA purification in a microfluidic system according to the invention can be carried out, for example, as follows: 10 5 Staphylococci in 1 ml of physiological saline solution are introduced by pumping via the inlet channel 56 or by pipetting into the vessel 54 in the system and pumped by the pump 52 through the filter 50. For lysis 100 ⁇ lysis buffer are pipetted into the vessel 54 and with the pump 52 for 10 minutes with simultaneous
  • Nucleic acids are effectively bound to the filter 50.
  • the filter 50 is then washed by pipetting a wash buffer into the vessel and pumping it via the filter 50 into the outlet channel 57.
  • the bound DNA is eluted with water by pipetting water into the vessel 54 and pumping it via the filter 50 into the outlet channel 57.
  • the eluate is collected.
  • a reference is processed: 10 5 staphylococci in 1 ml of physiological saline are collected by centrifugation at 13,000 g and the supernatant is pipetted off. 100 ⁇ l lysis buffer are added by pipette, mixed and incubated for 10 min at 45 ° C. The resulting lysate is successively mixed with digestion buffer and binding buffer and applied to a commercially available column.
  • FIG. 6 shows a section through an exemplary microfluidic filter chamber 60 based on a multilayer construction.
  • Lid films 63 form the multi-layer structure.
  • the filter 64 is in one
  • FIGS. 7 to 9 show an exemplary embodiment of a microfluidic system 700 for carrying out the method according to the invention.
  • Fig. 7 shows a top view from the front
  • Fig. 8 is a side view
  • Fig. 9 is an oblique view from the front.
  • the microfluidic system is implemented as a multilayer structure consisting of two structured polymer plates 750 and 760 (FIG. 8) and lid films arranged on the right and left or other polymer layers (not shown) for covering the structures.
  • the system comprises a pump 702, a vessel 704 with a ventilation opening 724 and a filter device 710 and a plurality of valves 708, 718, 728.
  • the fluid is guided in the direction of the arrow (FIGS. 7, 9), whereby the direction of flow can also be reversed.
  • the fluid is guided in the direction of the arrow (FIGS. 7, 9), whereby the direction of flow can also be reversed.
  • the fluid is guided in the direction of the arrow (
  • Filter device 710 is provided by a recess 713 (filter chamber) in the
  • Polymer plate 750 a frit 711 for the mechanical support of the filter and the actual filter 712 formed (Fig. 8).
  • channels 701 which are capped by cover sheets or other polymer layers (not shown).
  • the valves 708, 718, 728 are designed as microfluidic diaphragm valves.
  • the pump 702 is as
  • microfluidic diaphragm pump having a pumping chamber and an inlet valve 708 and two outlet valves 718, 728 and located downstream of the filter device 710.
  • the outlet valves 718, 728 form a T-junction and allow switching of the fluid path between the circuit 701 (valve 728) and the outlet channel 707 (valve 718).
  • Between the polymer plates 750 and 760 is a polymer membrane, not shown, which is used for pneumatic actuation of the valves and the pump.
  • the vessel 704 is shaped so that even the smallest amounts of liquid converge at the lowest point of the vessel and from there into the channel system 701 can enter.
  • the vessel 704 has a taper towards the bottom.
  • the illustrated system 700 may be part of a larger microfluidic system that includes other functionalities, e.g. more pumps and
  • the method of the invention may be performed as follows: The sample is first introduced into the vented vessel 704, e.g. by pipetting and pumping, and
  • Lysis buffer is then introduced into the vented vessel 704 and circulated through the filter device 710 during lysis with the pump 702.
  • the lysis buffer may also be circulated only briefly to safely fill the filter chamber 713 with liquid, after which, e.g. Heat or ultrasound is applied to the filter 712.
  • a binding buffer is placed in the vented vessel 704 and circulated by the pump 702 via the filter device 710. This results in the mixing of lysate and binding buffer and nucleic acids (as an example of molecules to be purified) bind to the filter 712.
  • the mixture is then pumped into the outlet channel 707.
  • a washing buffer is introduced into the ventilated vessel 704 and pumped via the filter device 710 into the outlet channel 707.
  • an elution buffer is introduced into the vented vessel 704 and pumped via the filter device 710 into the outlet channel 707.
  • the elution buffer can also be sucked in via the outlet channel 707 and pumped in the reverse direction via the filter device 710 into the ventilated vessel 704.
  • human cells initially present in the sample can be selectively lysed.
  • a digestion of proteins can be carried out after the lysis.
  • a denaturation step can be carried out before the binding of the DNA.
  • the pumping direction can be reversed briefly, for example, for 5 to 60 seconds.
  • FIG. 10 is a side view and FIG. 11 is a plan view of an exemplary one
  • Embodiment of a filter chamber 813 for microfluidic devices In Fig. 10, the multilayer structure of two polymer plates 850 and 860 can be seen.
  • the circular recess 814 in the polymer plate 850 is provided as a blind hole for inserting a filter membrane or a filter material bed and optionally a frit.
  • a circular extension 815 is provided Immediately above the filter to be inserted.
  • a circular aperture 816 is provided in the other polymer plate 860, which is covered in the assembled state by a cover membrane (not shown). Via the channel 817, a supply or discharge of liquids can take place.
  • the circular aperture 816 may, for example, have a diameter between 5 and 50 mm and may be arranged approximately concentrically with the filter, but may also be displaced, in particular with respect to the direction of gravity upward, e.g. by the difference between the radii of the filter and the circular area.
  • ultrasound can be introduced into the interior of the filter chamber 813 by means of a sonotrode, as a result of which ultrasound lysis can be carried out.
  • This variant has the advantage that a particularly efficient ultrasonic lysis is possible.
  • the area provided for introducing ultrasound can also be oval, square or oblong with comparable dimensions.
  • this variant has the advantage that the extension 815 of the filter chamber 813 can simultaneously fulfill the function that air bubbles rise upwards in the extension and are thus eliminated from the fluid circuit and that a volume of liquid rising during processing is absorbed, and thus optionally replace other vessel of the system.
  • an additional vent channel 819 may be provided. It is useful if the
  • Extension has a volume between 500 ⁇ and 5 ml.
  • an additional extension 818 can be provided.
  • a filter here, for example, silica membranes, but also beds of microparticles can be used.
  • the filter or the bed of microparticles extends into the extension 815 and the opening 816, so that there is contact with the cover membrane on this side. This has the advantage that when coupling of Ultrasound in the lid memb ran the filter or the bed of microparticles is particularly efficiently vibrated, whereby the lysis of accumulated cells can take place with greater yield.
  • FIGS. 12 and 13 show a further embodiment of a filter chamber 913 which, comparable to the filter chamber 813, has a blind-hole-shaped recess 914 in the polymer plate 950 for receiving a filter or a filter material bed and possibly a frit.
  • a filter chamber 913 which, comparable to the filter chamber 813, has a blind-hole-shaped recess 914 in the polymer plate 950 for receiving a filter or a filter material bed and possibly a frit.
  • About the channel 919 can a
  • Polymeric plate 960 has in these areas an aperture 916 which, when assembled, makes the connection between the blind hole 914 and the extension 915 and which is covered with a cover membrane (not shown).
  • the extension 915 and the aperture 916 similarly to the embodiment 813, are also suitable for ultrasonic coupling.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Water Supply & Treatment (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne un procédé et un dispositif de purification de molécules biologiques, notamment d'acides nucléiques ou de protéines, au moyen d'au moins un filtre (50). Au moins quelques-uns des liquides nécessaires à la conduite du procédé sont pompés dans un circuit (51) en passant par le filtre (50). Dans un premier temps, un liquide comprenant des cellules biologiques est pompé en passant par le filtre (50). Les cellules retenues sur le filtre sont ouvertes. Pour lier les molécules biologiques au filtre, un tampon de liaison est pompé dans le circuit (51) en passant par le filtre (50). Un tampon de lavage pour la purification des molécules biologiques liées au filtre est pompé en passant par le filtre (50) si bien que les molécules biologiques liées au filtre sont disponibles pour une utilisation ultérieure.
EP15717482.2A 2014-04-25 2015-04-17 Procédé et dispositif de purification de molécules biologiques Withdrawn EP3134505A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102014207774.5A DE102014207774B4 (de) 2014-04-25 2014-04-25 Verfahren und Vorrichtung zur Aufreinigung von biologischen Molekülen
PCT/EP2015/058348 WO2015162059A1 (fr) 2014-04-25 2015-04-17 Procédé et dispositif de purification de molécules biologiques

Publications (1)

Publication Number Publication Date
EP3134505A1 true EP3134505A1 (fr) 2017-03-01

Family

ID=52991729

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15717482.2A Withdrawn EP3134505A1 (fr) 2014-04-25 2015-04-17 Procédé et dispositif de purification de molécules biologiques

Country Status (7)

Country Link
US (1) US20170044483A1 (fr)
EP (1) EP3134505A1 (fr)
JP (1) JP2017515500A (fr)
KR (1) KR20160145610A (fr)
CN (1) CN106232799A (fr)
DE (1) DE102014207774B4 (fr)
WO (1) WO2015162059A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2942394A1 (fr) 2014-05-09 2015-11-11 Molzym GmbH & Co. KG Nouveau procédé permettant d'isoler un ADN microbien
DE102015204882A1 (de) * 2015-03-18 2016-09-22 Robert Bosch Gmbh Aufreinigungseinheit zum Aufreinigen zumindest einer Substanz aus einer Probenflüssigkeit, Aufreinigungsvorrichtung, Verfahren zum Betreiben einer Aufreinigungseinheit und Verfahren zum Herstellen einer Aufreinigungseinheit
EP3299804A1 (fr) * 2016-09-27 2018-03-28 Georg Fischer JRG AG Procédé et dispositif d'analyse de la densité bactérienne dans l'eau potable
DE102016222032A1 (de) * 2016-11-10 2018-05-17 Robert Bosch Gmbh Mikrofluidische Vorrichtung und Verfahren zur Analyse von Nukleinsäuren
DE102017219178A1 (de) * 2017-10-26 2019-05-02 Robert Bosch Gmbh System und Verfahren zur Entgasung eines Fluids in einer insbesondere mikrofluidischen Vorrichtung
CN107754433B (zh) * 2017-11-23 2023-09-01 昌微系统科技(上海)有限公司 一种用于微器件的过滤装置
KR102056938B1 (ko) * 2018-01-26 2019-12-17 (주)메타포어 매트릭스 구조를 가진 멤브레인 구조체 및 이를 이용한 생체분자 필터
IL263127B (en) * 2018-11-19 2022-07-01 The Interdisciplinary Center Herzliya Cc A liquid-based biological system
CN118103491A (zh) * 2021-09-08 2024-05-28 舒万诺知识产权公司 收获生物制剂的方法
WO2023098784A1 (fr) * 2021-12-01 2023-06-08 南京金斯瑞生物科技有限公司 Dispositif de raccordement auxiliaire
WO2024013952A1 (fr) * 2022-07-14 2024-01-18 株式会社日立ハイテク Procédé de commande de transport de liquide dans un trajet d'écoulement d'analyseur de biomolécules à l'aide d'un ordinateur, et système de purification de biomolécules

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346999A (en) * 1985-01-18 1994-09-13 Applied Biosystems, Inc. Method of nucleic acid extraction
JPH04210698A (ja) * 1990-12-06 1992-07-31 Sumitomo Electric Ind Ltd 生体物質分取法
WO1994021780A1 (fr) * 1993-03-18 1994-09-29 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture Appareil de determination quantitative d'analytes particulaires
US5468847A (en) * 1994-03-10 1995-11-21 Minnesota Mining And Manufacturing Company Method of isolating and purifying a biomacromolecule
US6011148A (en) * 1996-08-01 2000-01-04 Megabios Corporation Methods for purifying nucleic acids
WO1999033559A1 (fr) * 1997-12-24 1999-07-08 Cepheid Cartouche de manipulation de fluide integree
US6249014B1 (en) * 1998-10-01 2001-06-19 Ramtron International Corporation Hydrogen barrier encapsulation techniques for the control of hydrogen induced degradation of ferroelectric capacitors in conjunction with multilevel metal processing for non-volatile integrated circuit memory devices
US6958392B2 (en) * 1998-10-09 2005-10-25 Whatman, Inc. Methods for the isolation of nucleic acids and for quantitative DNA extraction and detection for leukocyte evaluation in blood products
US6214221B1 (en) * 1999-02-22 2001-04-10 Henry B. Kopf Method and apparatus for purification of biological substances
US6454456B2 (en) * 2000-03-08 2002-09-24 Browne & Co., Ltd. Kitchen utensil with wire loops covered with heat resistant resilient tubing
US7536813B2 (en) * 2002-06-18 2009-05-26 Lueddecke Harold M Segmented wagon wheel design
DE102005009479A1 (de) 2005-03-02 2006-09-07 Molzym Gmbh & Co. Kg Verwendung von Nukleasen zum Abbau von Nukleinsäure in Gegenwart von chaotropen Agenzien und/oder Tensiden
DE102006041396A1 (de) * 2006-09-04 2008-03-06 Robert Bosch Gmbh Mikrosieb zur Filterung von Partikeln in Mikrofluidik-Anwendungen und dessen Herstellung
JP2009207459A (ja) * 2008-03-06 2009-09-17 Sony Corp 核酸抽出装置、及び核酸抽出方法
US8546127B2 (en) * 2008-06-30 2013-10-01 General Electric Company Bacteria/RNA extraction device
WO2010009415A1 (fr) * 2008-07-18 2010-01-21 Canon U.S. Life Sciences, Inc. Procédés et systèmes pour une préparation d'échantillon d'adn microfluidique
WO2010057318A1 (fr) * 2008-11-24 2010-05-27 Early Warning Inc. Dispositifs et procédés pour distribuer des condensats de biomolécule concentrés à des dispositifs de biodétection
DE102010030962B4 (de) 2010-07-06 2023-04-20 Robert Bosch Gmbh Verfahren zur aktiven Hybridisierung in Microarrays mit Denaturierungsfunktion
AU2011281982B2 (en) * 2010-07-20 2015-12-17 Bavarian Nordic A/S Method for harvesting expression products
DE102010043015B4 (de) * 2010-10-27 2019-12-19 Robert Bosch Gmbh Verfahren zur Konzentration von Probenbestandteilen und Amplifikation von Nukleinsäuren
DE102010043030A1 (de) * 2010-10-28 2012-05-03 Robert Bosch Gmbh Mikrofluidische Vorrichtung und mikrofluidisches Verfahren zur Verarbeitung von Biopartikeln
DE102011007035A1 (de) * 2011-04-08 2012-10-11 Robert Bosch Gmbh Verfahren, LOC und Analysevorrichtung zur Lyse von Zellen und PCR-Amplifikation
DE102011078278A1 (de) * 2011-06-29 2013-01-03 Siemens Aktiengesellschaft Verfahren zur Bilderzeugung und Bildauswertung
DE102013215570A1 (de) * 2013-08-07 2015-02-12 Robert Bosch Gmbh Verfahren und Vorrichtung zum Aufbereiten einer Zielzellen und Begleitzellen enthaltenden Probe biologischen Materials zum Extrahieren von Nukleinsäuren der Zielzellen
DE102013215575A1 (de) * 2013-08-07 2015-02-12 Robert Bosch Gmbh Verfahren und Vorrichtung zum Aufbereiten einer Zielzellen und Begleitzellen enthaltenden Probe biologischen Materials zum Extrahieren von Nukleinsäuren der Zielzellen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
None *
See also references of WO2015162059A1 *

Also Published As

Publication number Publication date
JP2017515500A (ja) 2017-06-15
DE102014207774B4 (de) 2015-12-31
WO2015162059A1 (fr) 2015-10-29
DE102014207774A1 (de) 2015-10-29
KR20160145610A (ko) 2016-12-20
US20170044483A1 (en) 2017-02-16
CN106232799A (zh) 2016-12-14

Similar Documents

Publication Publication Date Title
DE102014207774B4 (de) Verfahren und Vorrichtung zur Aufreinigung von biologischen Molekülen
DE112013003342B4 (de) Patrone zur biochemischen Verwendung und biochemische Verarbeitungsvorrichtung
EP1896858B1 (fr) Dispositif et procede de preparation d'un echantillon pour une analyse et dispositif et procede d'analyse d'un echantillon
DE102005054924B4 (de) Vorrichtung und Verfahren zum Extrahieren einer Abstrichprobe
DE102006002258B4 (de) Modul zur Aufbereitung einer biologischen Probe, Biochip-Satz und Verwendung des Moduls
WO2009098104A1 (fr) Procédé et dispositif pour le traitement automatisé d’un échantillon
DE102010003001B4 (de) Mikrofluidisches Dielektrophorese-System
WO2015018707A1 (fr) Procédé et dispositif pour traiter un échantillon de matière biologique contenant des cellules cibles et des cellules chaperons, de manière à extraire des acides nucéliques desdites cellules cibles
WO2018086897A1 (fr) Dispositif microfluidique et procédé pour l'analyse d'acides nucléiques
WO2015018647A1 (fr) Procédé et dispositif pour traiter un échantillon de matière biologique contenant des cellules cibles et des cellules chaperons, de manière à extraire des acides nucéliques desdites cellules cibles
WO2013072110A1 (fr) Élément filtrant microfluidique permettant de séparer des constituants d'un échantillon de fluide biologique
EP2937144B1 (fr) Procédé et système microfluidique destiné à la préparation de cellules organiques et procédé de production d'un système microfluidique destiné à la préparation de cellules organiques
EP2206780B1 (fr) Procédé et dispositif pour la réalisation d'un procédé de préparation d'un acide nucléique et/ou d'amplification
DE102010043015B4 (de) Verfahren zur Konzentration von Probenbestandteilen und Amplifikation von Nukleinsäuren
WO2007003318A2 (fr) Dispositif et procede pour l'homogeneisation par rotor/stator
DE102005063572B3 (de) Vorrichtung und Verfahren zum Extrahieren einer Abstrichprobe
EP2836584B1 (fr) Procédé de désagrégation de cellules biologiques
WO2023110319A1 (fr) Dispositif et procédé de séparation d'agglomérats tridimensionnels
WO2023083704A1 (fr) Dispositif et procédé de mise en œuvre d'étapes de procédé microfluidique
DE19817081B4 (de) Filtereinheit zur mehrstufigen Separation von biologischen Zellsuspensionen und Lösungen
DE102014200505A1 (de) Behälter und Vorrichtung für einen Aufschluss und/oder eine Homogenisierung eines Fluids sowie Verfahren zum Aufschließen und/oder Homogenisieren eines Fluids
DE202011106370U1 (de) Mobiles und automatisches Anreicherungsgerät für Mikroorganismen aus flüssigen Proben
DE102015204882A1 (de) Aufreinigungseinheit zum Aufreinigen zumindest einer Substanz aus einer Probenflüssigkeit, Aufreinigungsvorrichtung, Verfahren zum Betreiben einer Aufreinigungseinheit und Verfahren zum Herstellen einer Aufreinigungseinheit

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20161125

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20171121

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20180528